Early clinical research outcomes of the Total Body PET
Research at the facility is improving patient outcomes by setting new standards for ultra-low dose imaging, which could shape radiation…
18 June 2025
First dementia treatment drug approved for Australia, supported by NIF capacity
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia.…
16 June 2025
Sharing the Australian National Total Body PET Facility: a win–win for researchers and clinicians
The Australian National Total Body PET Facility, launched just over a year ago, has shown that sharing PET infrastructure has…
03 June 2025
Network models brain changes in motor neurone disease to develop imaging tools for clinicians
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease…
28 May 2025
Our Programs
-
Advanced Human Imaging
We provide cutting-edge imaging capabilities essential for studying brain function, disease states, aging, and drug development; and help address health challenges like dementia, epilepsy, stroke and mental health.
%22%20transform%3D%22translate(1.6%201.6)%20scale(3.11719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23a13e5f%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-1.50836%20-78.55657%2026.66037%20-.5119%2077.3%20126.7)%22%2F%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-90.5%2070.5%2054.2)%20scale(155%2026.60025)%22%2F%3E%3Cellipse%20cx%3D%22139%22%20cy%3D%22129%22%20rx%3D%2227%22%20ry%3D%22155%22%2F%3E%3Cellipse%20cx%3D%2275%22%20cy%3D%2216%22%20rx%3D%22155%22%20ry%3D%2224%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
-
Preclinical and Frontier Imaging
We provide specialised infrastructure for advanced imaging of preclinical models, plants, specimens, materials and minerals – advancing Australia’s industries and digitising its national-priority collections.
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%2311f2a4%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(13.01571%20186.03045%20-143.06359%2010.00952%20245.5%20386.6)%22%2F%3E%3Cellipse%20fill%3D%22%23020000%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(94%20-216.3%20467.4)%20scale(135.58927%20481.25)%22%2F%3E%3Cellipse%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-480.29644%20-30.28027%206.9927%20-110.9161%20264.1%2080.8)%22%2F%3E%3Cellipse%20fill%3D%22%2324d297%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(78.55915%206.61353%20-8.44936%20100.36615%20227.1%20393.8)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
-
Radiopharmaceuticals
We support the development of radiopharmaceuticals and enable access to cyclotrons for producing radioisotopes, vital for diagnosis and therapy.
%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23389289%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(25.6%20-703.3%20721.5)%20scale(105.05106%20206.74347)%22%2F%3E%3Cellipse%20fill%3D%22%231d1a79%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-129.02764%20-48.4983%2026.1805%20-69.65208%20300.1%20254.7)%22%2F%3E%3Cellipse%20fill%3D%22%234f9855%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-46.89363%20109.94059%20-57.0903%20-24.35108%20236.6%20376)%22%2F%3E%3Cellipse%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-93.7%20171.4%20-81.8)%20scale(118.22818%20484.37499)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
-
Imaging Data Collections and Partnerships
We play a pivotal role in creating imaging data collections of national priority, and working to deploy digital infrastructure and expertise to support critical medical research and facilitate applying AI solutions in healthcare.
%22%20transform%3D%22translate(1.6%201.6)%20scale(3.125)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23fffacb%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(23.03451%20-47.70655%2039.98513%2019.30632%2079.4%20121.9)%22%2F%3E%3Cellipse%20cx%3D%2276%22%20cy%3D%222%22%20rx%3D%2281%22%20ry%3D%2281%22%2F%3E%3Cellipse%20cx%3D%2276%22%20cy%3D%22255%22%20rx%3D%2285%22%20ry%3D%2285%22%2F%3E%3Cellipse%20fill%3D%22%23ffda90%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-14.2066%2025.5854%20-19.48385%20-10.81864%2081.2%20123.9)%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Advanced Human Imaging
We provide cutting-edge imaging capabilities essential for studying brain function, disease states, aging, and drug development; and help address health challenges like dementia, epilepsy, stroke and mental health.
Preclinical and Frontier Imaging
We provide specialised infrastructure for advanced imaging of preclinical models, plants, specimens, materials and minerals – advancing Australia’s industries and digitising its national-priority collections.
Radiopharmaceuticals
We support the development of radiopharmaceuticals and enable access to cyclotrons for producing radioisotopes, vital for diagnosis and therapy.
Imaging Data Collections and Partnerships
We play a pivotal role in creating imaging data collections of national priority, and working to deploy digital infrastructure and expertise to support critical medical research and facilitate applying AI solutions in healthcare.
Our Partners
